Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
1976 - 1977
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Meets generally accepted scientific standards, well documented and acceptable for assessment.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1977
Report date:
1977

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Method: other: according to H.F. Smyth et al.: Am. Ind. Hyg. Ass. J. 23, 95-107, (1962)
GLP compliance:
no
Remarks:
study was performed prior to GLP
Test type:
other: Inhalation hazard test
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
N-(2-aminoethyl)-1,3-propanediamine
EC Number:
236-882-0
EC Name:
N-(2-aminoethyl)-1,3-propanediamine
Cas Number:
13531-52-7
Molecular formula:
C5H15N3
IUPAC Name:
N1-(2-Aminoethyl)-1,3-propanediamine

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 226 g (mean)

Administration / exposure

Route of administration:
inhalation: vapour
Vehicle:
other: unchanged (no vehicle)
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Temperature in air chamber: 20°C
- Saturated vapour


Duration of exposure:
8 h
No. of animals per sex per dose:
6
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 1 days

Results and discussion

Mortality:
No mortality was observed.
Clinical signs:
other: attempt to escape, closure eyelid, eye irritation
Body weight:
No adverse effects observed.
Gross pathology:
Nothing abnormal detected.

Applicant's summary and conclusion